Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
2.100
-0.220 (-9.48%)
Mar 18, 2026, 12:08 PM EDT - Market open

RVPH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
8.277.898.085.365.252.14
Research & Development
14.6522.9131.4222.874.850.3
Total Operating Expenses
22.9330.839.528.2310.12.43
Operating Income
-22.93-30.8-39.5-28.23-10.1-2.43
Interest Income
0.220.360.40.18-00.11
Interest Expense
-0.02-0.02-0.03---1.45
Other Non-Operating Income (Expense)
-0.010.56-0.1-0.191.59-
Total Non-Operating Income (Expense)
0.190.90.26-0.011.59-1.35
Pretax Income
-22.74-29.9-39.24-28.24-8.52-3.78
Provision for Income Taxes
0.020.020.02-0.020.010
Net Income
-22.76-29.92-39.26-28.26-8.52-3.78
Net Income to Common
-22.76-29.92-39.26-28.26-8.52-3.78
Shares Outstanding (Basic)
321110
Shares Outstanding (Diluted)
321110
Shares Change (YoY)
72.46%39.28%21.94%31.95%383.10%-94.34%
EPS (Basic)
-9.20-18.00-33.00-29.00-11.60-24.80
EPS (Diluted)
-9.20-18.00-33.00-29.00-11.60-24.80
Free Cash Flow
--33.54-28.32-18.96-10.67-4.07
Free Cash Flow Per Share
--20.24-23.80-19.43-14.43-26.56
EBITDA
-22.93-30.8-39.5-28.23-10.1-2.43
EBIT
-22.93-30.8-39.5-28.23-10.1-2.43
Effective Tax Rate
-0.09%-0.07%-0.04%0.07%-0.07%-0.02%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q